Home » Authors » Kim Coghill

Articles by Kim Coghill

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...